The European Commission and AstraZeneca have ended their months-long legal dispute. The British-Swedish pharmaceutical company will deliver 200 million doses of its coronavirus vaccine by the end of March 2022. The Commission announced this on Friday morning.
The agreement expects AstzaZeneca to deliver 135 million doses to EU member states by the end of this year, of which 60 million will be delivered by the end of the third quarter of 2021. An additional 65 million doses will be delivered by the end of March 2022. The European Commission said in a call that This is to complement the 100 million doses received by the 27 member states on June 30. EU countries know exactly when to expect these deliveries. If AstraZeneca is again delayed, the company will offer a discount depending on the delay. The European Union will not pay any compensation for the delay that has already occurred.
There are significant differences in vaccination coverage in our Member States. The European Health Commissioner, Stella Kyriakides, said the continued availability of vaccines, including AstraZeneca, remains critical.” In addition, through the COVAX mechanism, the EU also wants to donate more vaccines to countries where the vaccination campaign has barely begun. AstraZeneca, in turn, said it was “extremely happy to have reached an agreement”.
The commission notes that it signed a contract with AstraZeneca worth 300 million doses in August 2020, but that these deliveries were soon postponed. This agreement also puts an immediate end Legal proceedings initiated by the European Union due to delayed delivery.
“Coffee buff. Twitter fanatic. Tv practitioner. Social media advocate. Pop culture ninja.”